BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23225780)

  • 21. Evaluation of loxoprofen and its alcohol metabolites for potency and selectivity of inhibition of cyclooxygenase-2.
    Riendeau D; Salem M; Styhler A; Ouellet M; Mancini JA; Li CS
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1201-3. PubMed ID: 14980665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of growth and expression of inflammation mediators in human leukemic cell line U-937 by a nutrient mixture.
    Roomi MW; Kalinovsky T; Roomi NW; Rath M; Niedzwiecki A
    Exp Oncol; 2013 Sep; 35(3):180-6. PubMed ID: 24084455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.
    Bratsos I; Jedner S; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
    J Inorg Biochem; 2008; 102(5-6):1120-33. PubMed ID: 18279961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of alkyl esters of caffeic and ferulic acids on tumor cell proliferation, cyclooxygenase enzyme, and lipid peroxidation.
    Jayaprakasam B; Vanisree M; Zhang Y; Dewitt DL; Nair MG
    J Agric Food Chem; 2006 Jul; 54(15):5375-81. PubMed ID: 16848520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
    Totzke G; Schulze-Osthoff K; Jänicke RU
    Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines.
    Hida T; Kozaki K; Muramatsu H; Masuda A; Shimizu S; Mitsudomi T; Sugiura T; Ogawa M; Takahashi T
    Clin Cancer Res; 2000 May; 6(5):2006-11. PubMed ID: 10815926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase-2 in cancer cells and macrophages induces colon cancer cell growth by cigarette smoke extract.
    Liu ES; Shin VY; Ye YN; Luo JC; Wu WK; Cho CH
    Eur J Pharmacol; 2005 Jul; 518(1):47-55. PubMed ID: 15993407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of cyclooxygenase (COX) enzymes by compounds from Daucus carota L. Seeds.
    Momin RA; De Witt DL; Nair MG
    Phytother Res; 2003 Sep; 17(8):976-9. PubMed ID: 13680840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cyclooxygenase (COX)-2 expression by Tet-inducible COX-2 antisense cDNA in hormone-refractory prostate cancer significantly slows tumor growth and improves efficacy of chemotherapeutic drugs.
    Dandekar DS; Lokeshwar BL
    Clin Cancer Res; 2004 Dec; 10(23):8037-47. PubMed ID: 15585639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.
    Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and cyclooxygenase inhibitory activities of some N-acylhydrazone derivatives of isoxazolo[4,5-d]pyridazin-4(5H)-ones.
    Unsal-Tan O; Ozden K; Rauk A; Balkan A
    Eur J Med Chem; 2010 Jun; 45(6):2345-52. PubMed ID: 20207453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, anti-inflammatory activity, and in vitro antitumor effect of a novel class of cyclooxygenase inhibitors: 4-(aryloyl)phenyl methyl sulfones.
    Harrak Y; Casula G; Basset J; Rosell G; Plescia S; Raffa D; Cusimano MG; Pouplana R; Pujol MD
    J Med Chem; 2010 Sep; 53(18):6560-71. PubMed ID: 20804197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase inhibitors not inhibit resting lung cancer A549 cell proliferation.
    Duan W; Zhang L
    Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):317-21. PubMed ID: 16618538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COX-2 inhibitors as radiosensitizing agents for cancer therapy.
    Davis TW; Hunter N; Trifan OC; Milas L; Masferrer JL
    Am J Clin Oncol; 2003 Aug; 26(4):S58-61. PubMed ID: 12902857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effects of Cox-1 and -2 inhibition on bladder and prostate cancer in vitro.
    Farivar-Mohseni H; Kandzari SJ; Zaslau S; Riggs DR; Jackson BJ; McFadden DW
    Am J Surg; 2004 Nov; 188(5):505-10. PubMed ID: 15546559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.